South African officials withhold findings of Caster Semenya’s gender test

London, Sep. 19 (ANI): Even before South African star athlete Caster Semenya’s gender was questioned at the World Championships in Berlin, Athletics South Africa (ASA) had found out and withheld the fact that she had internal testes, an e-mail exchange has revealed.

According to the e-mail exchanges published in the Mail and Guardian newspaper, ASA officials were aware of the findings of a Pretoria clinic that Semenya had internal testes and produced abnormal amounts of testosterone for a woman, Times Online reports.

It was ASA’s chief medical officer and team doctor, Harold Adams, who had suggested the need carrying out the tests on Semenya, 18, because of her deep voice, muscular body and facial hair, which later became a subject of controversy in Berlin.

Another email exchange shows that Adams later suggested that the results to be kept confidential while the South African team was in Berlin.

“Thinking about the current confidential matter, I would suggest we make the following decisions. 1. We get a gynae opinion and take it to Berlin. 2. We do nothing and I will handle these issues if they come up in Berlin,” the report quoted from Dr Adams’ email to ASA President Leonard Chuene and General Manager Molatelo Malehopo, as saying.

Following the IAAF establishing that Semenya was a hermaphrodite, South African officials not only angrily denounced it, but also denied carrying out their own tests.

Taking matters a step further, South African Sports Minister Makhenkesi Stofile lost his temper at a press conference and threatened to start a “third world war” if Semenya was banned from international competition because of her gender.

Earlier, Semenya’s ex-coach Wilfred Daniels had said the ASA had duped Semenya into thinking the gender test carried out on her were routine drug tests. (ANI)

Weight loss can prevent kidney disease progression in obese patients

Washington, Sept 18 (ANI): Shedding extra pounds can preserve kidney function in obese people with kidney disease, according to a new study led by Indian origin scientist from Cleveland Clinic.

Weight loss can improve a number of health problems, like it can improve control of diabetes, lower blood pressure and cholesterol levels, and reduce the effects of heart disease.

During the study, Dr Sankar Navaneethan, and his colleagues analysed the studies that examined the effects of weight loss interventions in obese kidney disease patients.

It showed that weight loss attained through diet and exercise reduces proteinuria (excess excretion of protein in the urine-a hallmark of kidney damage) and may prevent additional decline in kidney function in obese patients with kidney disease.

Studies also showed that surgical interventions normalize the filtration rate of the kidneys in obese patients with high filtration rates (a risk factor for the development of kidney disease).

While the findings imply that weight reduction may prevent the progression of kidney disease in obese kidney disease patients, the authors noted that there were only a small number of studies available for analysis and additional high-quality long-term studies on this topic are needed.

The study appears in Clinical Journal of the American Society Nephrology. (ANI)

Jolie takes adopted daughter Zahara on first visit to native Ethiopia

Washington, September 16 (ANI): Hollywood actress Angelina Jolie’s eldest daughter Zahara returned to her native Ethiopia for the first time since her adoption four years ago.

The four-year-old flew back home with her mother at the weekend.

It all happened when Jolie, currently in Kenya on a United Nations mission with partner Brad Pitt and their six children, broke away from the trip to cross the border into Ethiopia.

Zahara’s little sister Shiloh, 3, also accompanied them.

However, Pitt and the couple’s other four children stayed behind.

“On a trip to Kenya with their children, Angelina stopped in Dabaab Refugee Camp, and also flew to Ethiopia with Zahara and Shiloh for two days,” Contactmusic quoted a source as having told People.com.

“(It was) the first time Zahara had been back home since her adoption. The trip was about keeping up that culture for her,” the source added.

If reports are to be believed, Jolie is looking for a property to build a tuberculosis and AIDS clinic in Zahara’s name.

The Hollywood couple jointly founded a similar organisation to aid impoverished children-known as the Maddox Jolie-Pitt Project-after adopting their eight-year-old son Maddox from Cambodia in 2002. (ANI)

Malay vet extends service to pet owner by groping, sucking her breasts

Kuala Lumpur, Sep 9 (ANI): A Malay kindergarten teacher, who took her feverish pet squirrel to a veterinary clinic for treatment, had her breasts groped instead by the attending veterinarian.

According to the Harian Metro, the veterinarian had asked the 27-year old woman to place the squirrel inside her blouse to keep it warm, given its “erratic body temperature”.

But the squirrel got stuck on her bra strap, when the 52-year-old veterinarian asked her to take the animal out.

While helping the woman remove the squirrel, the veterinarian saw her breasts, started praising her figure, and allegedly told her to take care of her body and “beautiful breasts”.

Ampang OCPD Asst Comm Abd Jalil Hasan said that the veterinarian later began to demonstrate to her how to massage her breasts.

“He then took advantage by groping and sucking the victim’s breasts. The victim struggled to release herself before the doctor finally let her go,” the Star Online quoted him as saying.

“He told her she need not pay for the squirrel’s treatment and asked her to come again. But she decided to lodge a police report,” he added.

ACP Abd Jalil Hasan added that the veterinarian was arrested on September 7.

However, the squirrel died shortly after returning home. (ANI)

Statins may help treat ‘female sexual dysfunction’

London, Sept 9 (ANI): Cholesterol-lowering wonder drugs known as statins may help treat female sexual dysfunction (FSD), according to a new study.

Raised cholesterol levels, or hyperlipidemia, have been linked to erectile dysfunction in men, as the build-up of fats in blood vessel walls can reduce blood flow to erectile tissue.

Since some aspects of female sexual arousal also rely on increased blood flow to the genitals, Katherine Esposito and her colleagues at the Second University of Naples in Italy compared sexual function in premenopausal women with and without hyperlipidemia, reports New Scientist.

In the study, researchers found that females with hyperlipidemia reported significantly lower arousal, orgasm, lubrication, and sexual satisfaction scores than women with normal blood lipid profiles.

And 32 per cent of the women with abnormal profiles scored low enough on a scale of female sexual function to be diagnosed with FDS, compared with 9 per cent of women without normal levels. However, women’s sexual desire was not affected by hyperlipidemia.

In another research, Annamaria Veronelli at the University of Milan, Italy, and her colleagues found that female sexual dysfunction was also associated with diabetes, obesity and an underactive thyroid gland.

“These two papers suggest that there are strong connections between women’s sexual arousal and organic diseases in the same way that men’s sexual problems arise,” says Geoffrey Hackett, a urologist at the Holly Cottage Clinic in Fisherwick, UK.

“This is currently not even considered in women,” the expert added.

The study has been published in the Journal of Sexual Medicine. (ANI)

Turning off oncogene may inhibit lung cancer stem cells’ growth

Washington, Sep 9 (ANI): A lung cancer oncogene, called PKCiota, is necessary for the proliferation of lung cancer stem cells, and turning it off could act as a key for the treatment of this deadly disease, according to scientists at the Mayo Clinic campus in Florida.

These stem cells are rare and powerful master cells that manufacture the other cells that make up lung tumours, and are resistant to chemotherapy treatment.

The study also shows that an agent, aurothiomalate, being tested at Mayo Clinic in a phase I clinical trial substantially inhibits growth of these cancer stem cells.

“Our data indicate that PKCiota is required for the earliest steps in the development of lung cancer, which is the expansion of tumor-initiating cells or cancer stem cells,” said the study’s senior author, Dr. Alan Fields.

“Lung cancer stem cells appear to be the major drivers in many common lung cancers, and in order for a therapeutic treatment to be effective, it has to disrupt these cancer stem cells. We show that aurothiomalate, the agent now being tested in lung cancer patients, can, in fact, target these cells,” he added.

While aurothiomalate was once used to treat rheumatoid arthritis, the researchers have now discovered that it can also target PKCiota.

Currently, the agent is being tested in patients at Mayo Clinic’s sites in Minnesota and Arizona and, based on this phase I trial, a phase II human clinical trial is planned to combine aurothiomalate with agents targeted at other molecules involved in cancer growth.

“We had previously shown that PKCiota is required to maintain tumor growth, but what this study sought to determine is whether PKCiota is involved in the initial steps of lung cancer development,” said Fields.

Fields said that, in mice, an oncogene known as Kras is thought to transform normal lung stem cells into cancer stem cells, thereby initiating lung cancer.

In the present study, the researchers established a strain of mice in which Kras can be activated at the same time that the PKCiota gene is inactivated.

They found that when the PKCiota gene is inactivated, Kras was unable to cause errant growth and expansion of lung stem cells in mice, the process that initiates tumour formation.

“What this told us is that Kras requires PKCiota to transform the lung stem cells and make them proliferate. In other words, PKCiota is downstream from Kras, and is necessary for Kras to initiate lung tumor formation,” said Fields.

After discovering that aurothiomalate disables PKCiota, the researchers tested whether this agent is effective against lung cancer that develops due to Kras mutation.

“The drug showed potent inhibitory effects on the Kras-dependent proliferation of lung cancer stem cells both in cell culture and in animals,” said Fields.

“That further suggests that a drug like aurothiomalate could have an effect on tumors that are dependent on either Kras or PKCiota for growth and survival, and that is potentially a lot of cancers.

Aurothiomalate appears to be one of the few drugs available that can effectively target these critical cancer stem cells. In the clinic, however, it is likely that aurothiomalate will be most effective when combined with other agents designed to target other tumor survival pathways,” he added.

The study has been published in Cancer Research. (ANI)

Soon, simple jab to prevent prostate cancer

Washington, Sept 8 (ANI): A simple jab may soon help prevent prostate cancer, say researchers.

The research team from University of Utah and University of Columbia have identified a virus, known to trigger leukaemia, in malignant human prostate cancer cells.

The research team hopes that the virus, XMRV (Xenotropic murine leukemia virus-related virus), would open opportunities for developing diagnostic tests, vaccines, and therapies for treating the cancer.

“We found that XMRV was present in 27 percent of prostate cancers we examined and that it was associated with more aggressive tumours,” said Dr Ila R. Singh, associate professor of pathology at University of Utah and the study’s senior author.

“We still don’t know that this virus causes cancer in people, but that is an important question we’re going to investigate,” Singh added.

The study also makes it evident that XMRV is present in malignant cells, and that XMRV is a gammaretrovirus, a simple retrovirus first isolated from prostate cancers in 2006 by researchers at the University of California, San Francisco (UCSF), and the Cleveland Clinic, known to cause cancer in animals.

During the study, the researchers examined more than 200 human prostate cancers, and compared them to more than 100 non-cancerous prostate tissues.

They found 27 percent of the cancers contained XMRV, compared to only 6 percent of the benign tissues.

The viral proteins were found almost exclusively in malignant prostatic cells, suggesting that XMRV infection may be directly linked to the formation of tumors.

The study is published in the Proceedings of the National Academy of Sciences. (ANI)

Single gene behind essential tremor, Parkinson’s disease identified

Washington, September 2 (ANI): A single gene promotes development of essential tremor in some patients and Parkinson’s disease in others has been identified by an international team of researchers.

In a study report published in Parkinsonism and Related Disorders, Mayo Clinic researchers in Florida and their collaborators worldwide note that patients with essential tremor shake when they move, while those with Parkinson’s disease shake when they are at rest.

They further state that a variant in LINGO1, a gene involved in neuronal survival, is the first proven evidence of a common genetic component in the development of both disorders.

Analysing their findings, the researchers have come to the conclusion that mutations in this gene are potentially responsible for five percent of patients with Parkinson’s disease, and five percent of patients with essential tremor.

Lead researcher Dr. Carles Vilarino-Guell, of Mayo Clinic, said: “There is a mutation in the gene that must be causing or contributing to Parkinson’s disease in some people and essential tremor in others.”

He, however, added that that did not mean that people with essential tremor have an increased risk of developing Parkinson’s disease.

The findings are intriguing because “although essential tremor and Parkinson’s disease are considered to be different diseases, researchers have been arguing for a long time about whether essential tremor is a milder, preliminary form of Parkinson’s disease, and they have been looking for the genetic connection between these disorders,” he said.

“Now we know LINGO1 is the first gene identified,” he added.

The scientists have yet to identify any specific mutation or mutations on LINGO1 responsible for either disorder.

“The easiest explanation is that there are two separate and clearly distinct mutations in the gene contributing to the disorders. But because this gene doubles the risk of developing either disease and it is found at the same frequency in both diseases, it is possibly the same mutation,” Dr. Vilarino-Guell said.

“Both diseases are also affected by environmental factors, and that may influence which disorder a person would be more likely to develop,” he added. (ANI)

Novel method to make safer human stem cells uses just one gene

London, Aug 29 (ANI): Inching closer to curing diseases like Parkinson’s using cells generated from a patient’s own body, researchers have successfully reprogrammed human nerve cells back to an embryo-like state by using just a single gene.

It is known that embryonic stem cells are pluripotent – they can develop into any of the body’s cell types.

But such cells are not available in large numbers, as they can only be harvested from a donated egg or embryo, and, for ethical reasons, most countries have laws restricting their use.

In 2006, Shinya Yamanaka and his colleagues at Kyoto University in Japan successfully made mouse cells pluripotent by reprogramming skin cells into a state like embryo cells.

They did so by using retroviruses to insert four genes – known as “factors” – into the cells’ DNA.

They repeated the trick a year later with human cells.

However, using genes and retroviruses in this way increases the risk of the cell becoming cancerous, not just because tinkering with DNA has that effect, but also because two of the four factors are known to cause cancer.

In a bid to make these promising cells in a safe way, Hans Scholer’s team at the Max Planck Institute for Molecular Biomedicine in Münster, Germany, has been working to achieve pluripotency using fewer factors.

Last year, they did this with the two factors that do not cause cancer, and now they have simplified the recipe further, doing it with just one.

“Remarkably, it turns out that three of these four essential factors are already expressed in human neural stem cells – although not in skin cells – so we only needed to add one factor, OCT4,” New Scientist quoted Boris Greber, a member of the team, as saying.

He said that the cells from neural tissue are much easier to reprogram than skin cells, and are less prone to mutations.

It is much harder to get a sample of neural stem cells than skin cells, as it can be done via extracting the cells from the dental pulp of teeth, said Greber.

Inserting even one gene into the chromosome of a cell still permanently modifies its DNA, which is why the new method will remain a lab tool instead of being allowed in the clinic.

However, the researchers are hoping that it will help them improve methods for producing embryonic stem cells.

“Ideally, we will be able to find a chemical that does the same job of expressing the factor without the need for a gene,” said Greber.

Earlier this year, researchers in California managed just that when they reprogrammed mouse fibroblasts using a cocktail of proteins.

That technique did not involve inserting genes, and, thus, shouldn’t raise the cancer risk. But that was far less efficient.

“Without stable intervention using viruses, the frequency of reprogramming goes down and you have to wait a long time. We don’t have the perfect method yet,” said Greber.

The study has been published in the journal Nature. (ANI)

MJ’s ex wife tipped cops about drug doc

London, August 27 (ANI): Michael Jackson’s former wife reportedly tipped cops about how doctor Arnold Klein helped supply the star with powerful drugs.

Debbie Rowe, who used to work as an assistant at Klein’s Beverly Hills clinic, was said to have secretly informed authorities how the singer used aliases to get the drugs from the plastic surgeon, who treated Jackson for 20 years.

Court papers apparently state that detectives got a tip-off from “an unknown female caller”, who revealed Jackson used names such as Omar Arnold, Fernand Diaz and Peter Madonie when he saw the medic.

Klein was purportedly accused of helping Jackson stock sedatives including powerful anaesthetic propofol that is believed to have caused his death.

“Rowe holds Klein totally responsible for Jackson’s drug addiction,” the Sun quoted sources as saying.

“She believes there is no way he could have got hooked without the help of Klein – and she is potentially the only one who can prove it.

“She must have suspected what was going on for years.

“She could really put the boot into Klein and she has good reason to. It makes her skin crawl to think Klein is the biological father of her kids, like reports suggest,” the sources added. (ANI)

Oral asthma controllers more effective than inhalers

Washington, Aug 26 (ANI): Asthmatic patients are more likely to benefit from oral controllers than inhalers, say Mayo clinic researchers.

“Clinical superiority of the inhaled products has been well documented in clinical trials and the HealthCore study confirmed this for those who take their medication properly,” said Dr. Joseph Singer, vice president of clinical affairs for HealthCore, the outcomes research subsidiary for WellPoint, Inc.

“However, we were surprised to discover that in looking at all patients in real-world settings, oral controllers appeared to be a better choice of treatment because of better compliance.

“Patients with the best outcomes were those who were compliant with inhaled corticosteroids,” he added.

During the study, researchers looked at 55, 000 patients from eight health plans who had used at least one of six types of asthma controller medications between 2003 and 2005.

Both oral and inhaled treatments offered comparable impacts on patient-reported quality of life and productivity.

Among patients taking more than one drug to control their asthma, HealthCore found that a combination of inhaled corticosteroids and long-acting beta-agonists were the best course of treatment in terms of better clinical outcomes and better quality of life.

In the group of patients who adhered to their medication, those taking leukotriene modifiers-oral asthma controllers-were more likely to have an emergency room or inpatient physician visit, less likely to use six or more short-acting beta agonist canisters and incurred higher annual costs.

“It’s important for physicians and health plans alike to know that ‘one size fits all’ does not apply when treating asthma patients,” said Singer.

“These results speak to the power of comparative effectiveness research and its ability to give physicians the information they need to customize treatment for patients in the real world,” he added. (ANI)

Pink concert alerts Oz woman to her ballooning breast implant

Cairns, Aug 20 (ANI): An Aussie woman, who woke up with one breast double the size of the other, said that had she not attended American singer Pink’s concert, she would not have known there was a problem with her breast implant.

Cattle station worker Kimberley Koy’s breast had ballooned out overnight after a plane trip to Sydney to see Pink perform, and fearing that it might be breast cancer, she immediately visited her doctor.

But at the clinic, Koy came to know that the breast problem had started a week earlier, when she was stabbed in the chest by a runaway cow’s horn while working on a Cape York property.

Koy, who has C-cup silicone gel breast implants, had brushed the incident off as the horn did not break her skin or leave a bruise, and was oblivious to the damage it had done to her implant until it popped up after the plane flight.

“When I told the doctor I’d flown she said, ‘That makes perfect sense because air pressure forced out the silicone’,” Cairns.com.au quoted her as saying.

“I could have gone years without knowing.

“When I woke up the day after the plane trip it was double the size of my right one … I thought I had breast cancer.

“If I hadn’t have gone to the Pink concert I wouldn’t have known my breast was leaking,” she said.

Koy said that her breast had since shrunk, but still edged out further than the right one.

“It was like a coconut to an orange; it was bloody weird and incredibly noticeable,” she said.

“I just wanted everyone to hear my story because I think it is very funny.

“It felt like one breast had filled up with milk and the other hadn’t,” she added. (ANI)

Injured Hargreaves in Germany to save Man U career

London, Aug.9 (ANI): Owen Hargreaves has secretly flown to Germany in a bid to save his Manchester United career.

According to The Sun, the England midfielder, 27, has been having treatment all week at the Munich clinic of top knee specialist Dr Hans Muller-Wolfahrt.

Hargreaves went to Munich after his latest setback and, although Sir Alex Ferguson said Hargreaves would return in ‘two to three weeks’, Muller-Wolfahrt told the player it could take six months.

Hargreaves, who had been at Dr Richard Steadman’s surgery in Colorado, is expected to fly back to America this week for more rehabilitation.

The England star has not played for United since the 1-1 draw at Chelsea on September 21 2008. (ANI)

3-D mapping breakthrough helps docs remove fist-sized tumour from a woman’s brain

Washington, July 15 (ANI): Experts at the University of Cincinnati (UC) have successfully removed a fist-sized tumour from the brain of an Indiana woman, using a technology that involves the fusion of four different types of images into a 3-D map of a patient’s brain.

An eight-member team from the Brain Tumor Center at the UC Neuroscience Institute carried out the operation at University Hospital.

“This marks the culmination of one of the most important developments in brain tumor surgery in the last 100 years,” says Dr. John Tew, a neurosurgeon with the Mayfield Clinic, professor of neurosurgery and clinical director of the UC Neuroscience Institute.

For the surgery, Tew and his team fused and installed the multiple brain scans into a surgical guidance computer, whose function is similar to a global positioning system.

They say that the technology revealed the tumour’s relationship to all of the functional centres, electrical pathways and arteries and veins in the patient’s brain, which is why they were able to map out a safe pathway to the tumour.

“This fusion of images is exciting in that it allows us to maximize resection (removal) of the tumour while preserving function for the patient,” says Dr. James Leach, an associate professor of neuroradiology at UC who performed the processing and fusion of images.

Since early 2007, specialists have used the fusion of three types of imaging as a guide to stereotactic surgery-Magnetic resonance imaging (MRI) that creates detailed pictures of the body by detecting differences in magnetic signals between different types of tissues; functional magnetic resonance imaging (fMRI) that creates a series of images that capture blood oxygen levels in parts of the brain that are responsible for movement, perception and cognition; and diffusion tensor imaging (DTI) that provides a map of critical white-matter tracts, which facilitate electrical connections between different parts of the brain.

Leach revealed that the latest work added the fusion of computed tomography angiography (CTA), which provides a map of blood vessels-arteries and veins.

“The 3T system allows us to image the functional areas of the brain using various language, motor and vision tasks with the patient in the MRI scanner. The addition of the DTI sequence allows the connections between these areas and other parts of the nervous system to be identified at the same time,” Leach says.

Tew said that the three-dimensional brain-mapping enabled his team to navigate a trajectory through the patient’s brain, and to remove 90 percent of the malignant tumour, an anaplastic astrocytoma, without harming the healthy brain tissue-including the deep nerve-fibre tracts-that surrounded it.

According to the researcher, the patient was talking normally right after surgery, and she was walking the halls and able to take a shower without assistance one day after surgery. he team sought to eradicate the remaining tumour by applying a course of 33 computer-guided, fractionated radiotherapy treatments as a first approach. (ANI)

MJ saw op-ravaged face as ‘a work of art’, reveals dermatologist

London, July 9 (ANI): Late King of Pop Michael Jackson’s dermatologist has revealed that the singer considered his op-ravaged face to be “a work of art”.owever, Dr. Arnold Klein added: “I did not like what was happening so got him out of the hands of these plastic surgeons.”

He said so when he angrily broke his silence and denied any involvement in the ‘Thriller’ hitmaker’s death.

He insisted that eh singer had been in perfect health, and “danced in his office” when he saw him three days before his death.

Klein, however, refused to kill off the speculation that he might be the real father of Jackson’s children, Prince Michael, 12, and Paris, 11.

“To the best of my knowledge I am not the father. But if push comes to shove I cannot say anything about it,” the Mirror quoted him as saying.

He even denied that Jackson had wanted to change his colour.

“He was developing severe speckling and you can’t look like a leopard. You have to even your skin tone,” he said.

Klein further said that he was not worried about the late King of Pop’s other medics.

According to the paper, he told TV show Good Morning America: “No matter what he wanted someone would give it. The very rich, very poor and the very famous get the worst medical care.”

His former assistant Debbie Rowe met Jackson at his clinic, and married the star. (ANI)

20 cholesterol-regulating genes identified

Washington, July 8 (ANI): Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have identified 20 genes that play a vital role in maintaining cholesterol balance.

The researchers believe that the newly identified genes may help uncover the mechanisms that regulate cholesterol levels, and lead to new treatments for cholesterol-related diseases.

“This finding may open new avenues for designing targeted therapies, for example by looking for small molecules that could impact these genes,” said Heiko Runz, whose group at the University Clinic Heidelberg carried out the research together with Rainer Pepperkok’s lab at EMBL.

High levels of cholesterol in the bloodstream are a major risk factor for atherosclerosis and coronary heart disease.

During the study, the researchers deprived isolated human cells of cholesterol, and then looked at the whole genome to find the genes that react to changes in cholesterol levels by altering their expression.

With a microscope, they then observed what effect switching off different genes had both on cholesterol uptake and on the total amount of cholesterol inside cells.

Of the 20 genes the scientists identified as involved in regulating cholesterol levels and uptake, 12 were previously unknown.

The scientists are now trying to discover exactly how the novel genes regulate cholesterol levels inside cells, as well as looking at patients to determine whether these genes (or alterations in them) do constitute risk factors, and investigating if and how they could be useful drug targets.

The study appears in journal Cell Metabolism. (ANI)

Anna Kournikova spotted with diamond ring on engagement finger

Melbourne, July 07 (ANI): Anna Kournikova has been spotted with a huge diamond ring on her engagement finger.

The hot Tennis star, who has long been linked to singer Enrique Iglesias, showed off her ring when she came to watch World Team Tennis on Monday night, the Daily Telegraph reports.

However, when she was asked if the ring meant she was committed, she simply replied: “I thought you were the good press.”

The Russian bombshell became conscious and hid her hand behind her back.

Kournikova was scheduled to play for the St. Louis Aces but will miss the season because of a wrist injury.

She still participated in a kid’s clinic, signed autographs and cheered on her teammates. (ANI)

Jacko’s ex-wife fumes over British newspaper’s ‘fabricated’ paternity slur

Washington, June 30 (ANI): Michael Jackson’s ex-wife Debbie Rowe has slammed a British newspaper alleging the pop star was not the father of his two eldest children.

Britain’s News of the World quoted Rowe saying that she was artificially inseminated by an anonymous donor during their marriage and that she had no interest in obtaining custody of ‘Prince’ Michael Jr, 12, and 11-year-old Paris.

However, Rowe’s attorney, Marta Almli, has told RadarOnline.com that she has not yet answered questions about whether she will fight for custodial rights following Jackson’s sudden death.

“The interview did not occur. The article is a complete fabrication,” Contactmusic quoted Almli as saying.

Rowe – a receptionist at a Beverly Hills clinic where he got skin treatments – married Jackson in 1996 and divorced after three years. (ANI)

Susan Boyle back in form at Britain’s Got Talent London gig

London, June 22 (ANI): Susan Boyle has apparently regained her form, for she recently gave a stunning performance in London, as part of the ongoing Britain’s Got Talent tour.

The show’s runner-up previously pulled out of concerts in Manchester, Liverpool and two in Nottingham citing exhaustion.

But the singing sensation returned to claim her place in the hearts of the crowd at Wembley Arena, reports the Daily Star.

Susan has been under the careful eye of show bosses since her four-day stint in a rehab clinic after facing defeat in the finals of the talent competition.

The 48-year-old returned on stage, and has been wooing fans with her live performances. (ANI)

Cowell admits Boyle’s rise to fame could have been handled differently

London, June 21 (ANI): Britain’s Got Talent boss Simon Cowell has confessed that Susan Boyle’s phenomenal rise to fame and her subsequent emotional breakdowns could have been handled differently.

The show judge said show organisers could have been more careful in addressing Susan’s problems after she became an overnight star with her jaw dropping performance of her audition song.

“Looking back on it all, it has become clear to me that we didn’t handle the situation with Susan as well as we could have,” the Scotsman quoted him as saying.

“Yet, to be honest, I don’t know that I could have done it any differently,” he added.

Simon’s comments came as the show’s runner-up missed more live BGT concerts.

Susan sparked health concerns after a four-day stint at a rehab clinic following exhaustion after facing defeat in the show’s finals.

The 48-year-old later returned onstage and has been wooing fans with her live performances. (ANI)